DJIA 17,959.44 154.64 0.87%
NASDAQ 4,781.42 16.04 0.34%
S&P 500 2,078.54 7.89 0.38%
market minute promo

The Medicines Company (NASDAQ: MDCO)

company name or ticker
Company Photos
(Click to zoom)

Mid-Afternoon Market Update: Compuware Holds Onto Gains, Clearwire Remains Down

3 Stocks Underperforming Today In The Health Care Sector

Mid-Day Market Update: Verint Shares Jump On Upbeat Results; Medicines Co. Falls

Top Health Care Stories: The Medicines Company, Eli Lilly, and GlaxoSmithKline

MannKind, The Medicines Company, Eli Lilly, and GlaxoSmithKline could all make health care headlines this morning.

The Medicines Company Stock Downgraded (MDCO)

EU Review for The Medicines Co.'s Oritavancin - Analyst Blog

First Week of October 18th Options Trading For Medicines (MDCO)

After Cangrelor, The Medicines Company Gets Priority Review for New Drug

After its anti-clotting agent Cangrelor was rejected by an FDA committee, The Medicines Company sets its sights on getting approval for skin infection drug oritavancin.

The Medicines Co Posts Lower Y/Y Q4 Earnings - Analyst Blog

The Medicines Company CEO Discusses Q4 2013 Results - Earnings Call Transcript